Table 2.
Follow-Up Evaluation Before and 3 Months After AVR
| Before AVR | After AVR | p Value | |
|---|---|---|---|
| NYHA functional class III/IV, % | 44 | 9 | 0.021 |
| B-type natriuretic peptide, pg/ml | 338 ± 377 | 279 ± 143 | 0.568 |
| Aortic valve area, cm2 | 0.7 ± 0.1 | 1.7 ± 0.2 | <0.001 |
| Aortic mean gradient, mm Hg | 45 ± 9 | 9 ± 3 | <0.001 |
| Z, mm Hg/ml · m2 | 5.7 ± 2.1 | 4.2 ± 1.2 | 0.015 |
| Left ventricular ejection fraction, % | 59 ± 12 | 58 ± 8 | 0.749 |
| LVEDDI, cm/m2 | 2.5 ± 0.4 | 2.4 ± 0.3 | 0.086 |
| LVESDI, cm/m2 | 1.8 ± 0.5 | 1.6 ± 0.3 | 0.077 |
| LVMI, g/m2 | 139 ± 34 | 117 ± 30 | 0.002 |
Values are % or mean ± SD.
AVR = aortic valve replacement; other abbreviations as in Table 1.